315 related articles for article (PubMed ID: 793369)
1. Clinical efficacy of amiodarone as an antiarrhythmic agent.
Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Lubbe WF; Mercer CJ; Roche AH; Lowe JB
N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
[TBL] [Abstract][Full Text] [Related]
4. Ten years of experience with amiodarone.
Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
[TBL] [Abstract][Full Text] [Related]
5. Control of refractory cardiac arrhythmias with amiodarone.
Leak D; Eydt JN
Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone: a unique antiarrhythmic agent.
Sloskey GE
Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
[TBL] [Abstract][Full Text] [Related]
7. Clinical use and pharmacology of amiodarone.
Heger JJ; Prystowsky EN; Miles WM; Zipes DP
Med Clin North Am; 1984 Sep; 68(5):1339-66. PubMed ID: 6387328
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Zipes DP; Prystowsky EN; Heger JJ
J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone for refractory cardiac arrhythmias: 10-year study.
Leak D; Eydt JN
CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
[TBL] [Abstract][Full Text] [Related]
10. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
Chiale PA; Halpern MS; Nau GJ; Tambussi AM; Przybylski J; Lázzari JO; Elizari MV; Rosenbaum MB
Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Podrid PJ; Lown B
Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
Rowland E; Krikler DM
Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
[TBL] [Abstract][Full Text] [Related]
15. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.
Carrasco HA; Vicuña AV; Molina C; Landaeta A; Reynosa J; Vicuña N; Fuenmayor A; López F
Int J Cardiol; 1985 Dec; 9(4):425-38. PubMed ID: 3908329
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
[TBL] [Abstract][Full Text] [Related]
17. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
Leak D
Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone treatment in patients with ventricular arrhythmias.
Prystowsky EN; Heger JJ; Miles WM; Zipes DP
Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
Nademanee K; Hendrickson J; Kannan R; Singh BN
Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
[No Abstract] [Full Text] [Related]
20. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
